Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 9/2009

01.09.2009 | Article

A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections

verfasst von: A. Ardizzoni, B. Capuccini, M. C. Baschieri, C. F. Orsi, F. Rumpianesi, S. Peppoloni, C. Cermelli, M. Meacci, A. Crisanti, P. Steensgaard, E. Blasi

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

The detection of specific serum antibodies is mainly achieved by enzyme-linked immunosorbent assay (ELISA). Here, we describe the setting up of a microarray-based serological assay to screen for IgG and IgM against vertically transmitted pathogens (Toxoplasma gondii, rubella virus, cytomegalovirus, herpes simplex virus types 1 and 2, varicella zoster virus, Chlamydia trachomatis). The test, accommodated onto a restricted area of a microscope slide, consists of: (a) the immobilization of antigens and human IgG and IgM antibody dilution curves, laid down in an orderly manner; (b) addition of serum samples; (c) detection of antigen–serum antibodies complexes by indirect immunofluorescence. The IgG and IgM curves provide an internal calibration system for the interpolation of the signals from the single antigens. The test was optimized in terms of spotting conditions and processing protocol. The detection limit was 400 fg for the IgG assay and 40 fg for the IgM assay; the analytical specificity was >98%. The clinical sensitivity returned an average value of 78%, the clinical specificity was >96%, the predictive values were >73%, and the efficiency was >88%. The results obtained make this test a promising tool, suitable for introduction in the clinical diagnostic routine of vertically transmitted infections, in parallel (and in future as an alternative) to ELISA.
Literatur
1.
Zurück zum Zitat MacBeath G, Schreiber SL (2000) Printing proteins as microarrays for high-throughput function determination. Science 289:1760–1763PubMed MacBeath G, Schreiber SL (2000) Printing proteins as microarrays for high-throughput function determination. Science 289:1760–1763PubMed
2.
Zurück zum Zitat Nam MJ, Madoz-Gurpide J, Wang H, Lescure P, Schmalbach CE, Zhao R, Misek DE, Kuick R, Brenner DE, Hanash SM (2003) Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 3:2108–2115. doi:10.1002/pmic.200300594 PubMedCrossRef Nam MJ, Madoz-Gurpide J, Wang H, Lescure P, Schmalbach CE, Zhao R, Misek DE, Kuick R, Brenner DE, Hanash SM (2003) Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 3:2108–2115. doi:10.​1002/​pmic.​200300594 PubMedCrossRef
4.
Zurück zum Zitat Du H, Wu M, Yang W, Yuan G, Sun Y, Lu Y, Zhao S, Du Q, Wang J, Yang S, Pan M, Lu Y, Wang S, Cheng J (2005) Development of miniaturized competitive immunoassays on a protein chip as a screening tool for drugs. Clin Chem 51:368–375. doi:10.1373/clinchem.2004.036665 PubMedCrossRef Du H, Wu M, Yang W, Yuan G, Sun Y, Lu Y, Zhao S, Du Q, Wang J, Yang S, Pan M, Lu Y, Wang S, Cheng J (2005) Development of miniaturized competitive immunoassays on a protein chip as a screening tool for drugs. Clin Chem 51:368–375. doi:10.​1373/​clinchem.​2004.​036665 PubMedCrossRef
6.
Zurück zum Zitat Bacarese-Hamilton T, Mezzasoma L, Ingham C, Ardizzoni A, Rossi R, Bistoni F, Crisanti A (2002) Detection of allergen-specific IgE on microarrays by use of signal amplification techniques. Clin Chem 48:1367–1370PubMed Bacarese-Hamilton T, Mezzasoma L, Ingham C, Ardizzoni A, Rossi R, Bistoni F, Crisanti A (2002) Detection of allergen-specific IgE on microarrays by use of signal amplification techniques. Clin Chem 48:1367–1370PubMed
7.
Zurück zum Zitat Bacarese-Hamilton T, Gray J, Ardizzoni A, Crisanti A (2005) Allergen microarrays. Methods Mol Med 114:195–207PubMed Bacarese-Hamilton T, Gray J, Ardizzoni A, Crisanti A (2005) Allergen microarrays. Methods Mol Med 114:195–207PubMed
9.
Zurück zum Zitat Bacarese-Hamilton T, Ardizzoni A, Gray J, Crisanti A (2004) Protein arrays for serodiagnosis of disease. Methods Mol Biol 264:271–283PubMed Bacarese-Hamilton T, Ardizzoni A, Gray J, Crisanti A (2004) Protein arrays for serodiagnosis of disease. Methods Mol Biol 264:271–283PubMed
11.
Zurück zum Zitat Gray JC, Corran PH, Mangia E, Gaunt MW, Li Q, Tetteh KKA, Polley SD, Conway DJ, Holder AA, Bacarese-Hamilton T, Riley EM, Crisanti A (2007) Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin Chem 53:1244–1253. doi:10.1373/clinchem.2006.081695 PubMedCrossRef Gray JC, Corran PH, Mangia E, Gaunt MW, Li Q, Tetteh KKA, Polley SD, Conway DJ, Holder AA, Bacarese-Hamilton T, Riley EM, Crisanti A (2007) Profiling the antibody immune response against blood stage malaria vaccine candidates. Clin Chem 53:1244–1253. doi:10.​1373/​clinchem.​2006.​081695 PubMedCrossRef
12.
Zurück zum Zitat Ekins RP, Chu FW, Biggart E (1990) Multispot, multianalyte, immunoassay. Ann Biol Clin (Paris) 48:655–666 Ekins RP, Chu FW, Biggart E (1990) Multispot, multianalyte, immunoassay. Ann Biol Clin (Paris) 48:655–666
13.
Zurück zum Zitat Ekins RP, Chu FW (1992) Multianalyte microspot immunoassay. The microanalytical “compact disk” of the future. Ann Biol Clin (Paris) 50:337–353 Ekins RP, Chu FW (1992) Multianalyte microspot immunoassay. The microanalytical “compact disk” of the future. Ann Biol Clin (Paris) 50:337–353
15.
Zurück zum Zitat Gilbert GL (2002) Infections in pregnant women. Med J Aust 176:229–236PubMed Gilbert GL (2002) Infections in pregnant women. Med J Aust 176:229–236PubMed
19.
Zurück zum Zitat Dontigny L, Arsenault MY, Martel MJ, Biringer A, Cormier J, Delaney M, Gleason T, Leduc D, Martel MJ, Penava D, Polsky J, Roggensack A, Rowntree C, Wilson AK; Society of Obstetricians and Gyneacologist of Canada (2008) Rubella in pregnancy. J Obstet Gynaecol Can 30:152–168PubMed Dontigny L, Arsenault MY, Martel MJ, Biringer A, Cormier J, Delaney M, Gleason T, Leduc D, Martel MJ, Penava D, Polsky J, Roggensack A, Rowntree C, Wilson AK; Society of Obstetricians and Gyneacologist of Canada (2008) Rubella in pregnancy. J Obstet Gynaecol Can 30:152–168PubMed
20.
Zurück zum Zitat Engman ML, Malm G, Engstrom L, Petersson K, Karltorp E, Tear Fahnehjelm K, Uhlen I, Guthenberg C, Lewensohn-Fuchs I (2008) Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand J Infect Dis 40:935–942. doi:10.1080/00365540802308431 PubMedCrossRef Engman ML, Malm G, Engstrom L, Petersson K, Karltorp E, Tear Fahnehjelm K, Uhlen I, Guthenberg C, Lewensohn-Fuchs I (2008) Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand J Infect Dis 40:935–942. doi:10.​1080/​0036554080230843​1 PubMedCrossRef
22.
Zurück zum Zitat Stegmann BJ, Carey JC (2002) TORCH infections. Toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes infections. Curr Womens Health Rep 2:253–258PubMed Stegmann BJ, Carey JC (2002) TORCH infections. Toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cytomegalovirus (CMV), and herpes infections. Curr Womens Health Rep 2:253–258PubMed
25.
Zurück zum Zitat Hannon WH, Atkinson MA, Ball DJ, Goldsmith ML, Matsson PNJ, Whitley RJ (2001) Specifications for immunological testing for infectious diseases; approved guideline—second edition. Clinical and Laboratory Standards Institute (formerly NCCLS), vol 21, pp 1–42 Hannon WH, Atkinson MA, Ball DJ, Goldsmith ML, Matsson PNJ, Whitley RJ (2001) Specifications for immunological testing for infectious diseases; approved guideline—second edition. Clinical and Laboratory Standards Institute (formerly NCCLS), vol 21, pp 1–42
26.
Zurück zum Zitat Enright AM, Prober CG (2002) Neonatal herpes infection: diagnosis, treatment and prevention. Semin Neonatol 7:283–291PubMed Enright AM, Prober CG (2002) Neonatal herpes infection: diagnosis, treatment and prevention. Semin Neonatol 7:283–291PubMed
27.
Zurück zum Zitat Thorp JM Jr, Katz VL, Fowler LJ, Kurtzman JT, Bowes WA Jr (1989) Fetal death from chlamydial infection across intact amniotic membranes. Am J Obstet Gynecol 161:1245–1246PubMed Thorp JM Jr, Katz VL, Fowler LJ, Kurtzman JT, Bowes WA Jr (1989) Fetal death from chlamydial infection across intact amniotic membranes. Am J Obstet Gynecol 161:1245–1246PubMed
28.
Zurück zum Zitat Altman DG, Bland JM (1994) Diagnostic tests 2: predictive values. BMJ 309:102PubMed Altman DG, Bland JM (1994) Diagnostic tests 2: predictive values. BMJ 309:102PubMed
29.
Zurück zum Zitat Gabutti G, Rota MC, Guido M, De Donno A, Bella A, Ciofi Degli Atti ML, Crovari P; Seroepidemiology Group (2008) The epidemiology of Varicella Zoster virus infection in Italy. BMC Public Health 8:372–380. doi:10.1186/1471-2458-8-372 PubMedCrossRef Gabutti G, Rota MC, Guido M, De Donno A, Bella A, Ciofi Degli Atti ML, Crovari P; Seroepidemiology Group (2008) The epidemiology of Varicella Zoster virus infection in Italy. BMC Public Health 8:372–380. doi:10.​1186/​1471-2458-8-372 PubMedCrossRef
30.
Zurück zum Zitat Rota MC, Bella A, Gabutti G, Giambi C, Filia A, Guido M, De Donno A, Crovari P, Ciofi Degli Atti ML; Serological Study Group (2007) Rubella seroprofile of the italian population: an 8-year comparison. Epidemiol Infect 135:555–562. doi:10.1017/S0950268806007400 PubMedCrossRef Rota MC, Bella A, Gabutti G, Giambi C, Filia A, Guido M, De Donno A, Crovari P, Ciofi Degli Atti ML; Serological Study Group (2007) Rubella seroprofile of the italian population: an 8-year comparison. Epidemiol Infect 135:555–562. doi:10.​1017/​S095026880600740​0 PubMedCrossRef
31.
Zurück zum Zitat Suligoi B, Torri A, Grilli G, Tanzi E, Palú G; The Italian Herpes Management Forum (2004) Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy. Sex Transm Dis 31:608–610. doi:10.1097/01.olq.0000140013.60224.ba PubMed Suligoi B, Torri A, Grilli G, Tanzi E, Palú G; The Italian Herpes Management Forum (2004) Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy. Sex Transm Dis 31:608–610. doi:10.​1097/​01.​olq.​0000140013.​60224.​ba PubMed
32.
Zurück zum Zitat Pasquini P, Mele A, Franco E, Ippolito G, Svennerholm B (1988) Prevalence of herpes simplex virus type 2 antibodies in selected population groups in Italy. Eur J Clin Microbiol Infect Dis 7:54–56. doi:10.1007/BF01962174 PubMedCrossRef Pasquini P, Mele A, Franco E, Ippolito G, Svennerholm B (1988) Prevalence of herpes simplex virus type 2 antibodies in selected population groups in Italy. Eur J Clin Microbiol Infect Dis 7:54–56. doi:10.​1007/​BF01962174 PubMedCrossRef
33.
Zurück zum Zitat Latino MA, Bello L, Lanza A, Leotta E, Tersiev P, De Intinis G, Spagnolo E, Smirne C, Grio R (2002) Chlamydia trachomatis infection among sexually active young women in Italy. Sex Transm Infect 78:305–307. doi:10.1136/sti.78.4.305 CrossRef Latino MA, Bello L, Lanza A, Leotta E, Tersiev P, De Intinis G, Spagnolo E, Smirne C, Grio R (2002) Chlamydia trachomatis infection among sexually active young women in Italy. Sex Transm Infect 78:305–307. doi:10.​1136/​sti.​78.​4.​305 CrossRef
Metadaten
Titel
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections
verfasst von
A. Ardizzoni
B. Capuccini
M. C. Baschieri
C. F. Orsi
F. Rumpianesi
S. Peppoloni
C. Cermelli
M. Meacci
A. Crisanti
P. Steensgaard
E. Blasi
Publikationsdatum
01.09.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 9/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-009-0748-y

Weitere Artikel der Ausgabe 9/2009

European Journal of Clinical Microbiology & Infectious Diseases 9/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.